VOROZOLE is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Rivizor, Vorozolum, 6-((4-chlorophenyl)-(1H-1, 2 and 4-triazol-1-yl)methyl)-1-methyl-1H-benzotriazole. Its PubChem CID is 6918191.
(+)-Vorozole
| CAS No | 129731-10-8 |
|---|---|
| Molecular Formula | C16H13ClN6 |
| Molecular Weight | 324.77 g/mol |
| Synonyms | 6-[(S)-(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
VOROZOLE is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin.
The listed CAS number is 129731-10-8.
The listed molecular formula is C16H13ClN6.
The listed molecular weight is 324.77 g/mol.
6-[(S)-(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole.
The source lists Rivizor, Vorozolum, 6-((4-chlorophenyl)-(1H-1, 2 and 4-triazol-1-yl)methyl)-1-methyl-1H-benzotriazole.